![]() |
|
written by Abeer A. Al-Refai, Safaa I. Tayel, Ahmed Ragheb, Ashraf G. Dala, Ahmed Zahran ,
published by Open Journal of Nephrology, Vol.4 No.1, 2014
has been cited by the following article(s):
[1]
Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy
Reviews in Endocrine and Metabolic Disorders
2017
[5]
Dapagliflozin attenuates early markers of diabetic nephropathy in fructose-streptozotocin-induced diabetes in rats
Biomedicine & Pharmacotherapy
2019
[6]
Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
2018
[8]
Urinary Neutrophil Gelatinase-Associated Lipocalin in Type 2 Diabetes: Relation to Nephropathy and Retinopathy
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
2018
[9]
Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as early markers of diabetic nephropathy
Annals of African medicine
2017
[10]
Neutrophil gelatinase associated lipocalin (NGAL) in early detection of nephropathy in type 2 diabetic Iraqi patients
J Fac Med Baghdad
2017
[11]
Uninephrectomized high-fat-fed nicotinamide-streptozotocin-induced diabetic rats: a model for the investigation of diabetic nephropathy in type 2 diabetes
Journal of Diabetes Research
2016
[12]
Urinary Markers of Tubular Injury in Early Diabetic Nephropathy
International Journal of Nephrology
2016
[13]
Oxidized-LDL, Toll-like Receptor 4, Lipocalin 2 and Omentin1: Role in Diabetic Nephropathy
International Journal of Biochemistry Research & Review
2016
[14]
Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients
Biomarker research
2015
[15]
Urinary Excretion of Neutrophil Gelatinase-Associated Lipocalin in Diabetic Rats
Oxidative medicine and cellular longevity
2014